We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Gene Missense Variant Associated with Crohn's Disease

By LabMedica International staff writers
Posted on 21 Feb 2019
Gene-microbiome interactions are important in etiology and pathogenesis of inflammatory bowel disease, a chronic inflammatory disorder of the gastrointestinal tract consisting of Crohn’s disease and ulcerative colitis. More...
This latter condition causes long-lasting inflammation and sores (ulcers) in the innermost lining of the large intestine (colon) and rectum.

Inflammatory bowel disease (IBD) is a common, chronic disorder of the gastrointestinal tract. Patients with this disease experience periods of inflammation alternated by periods of remission. The most common subgroups of IBD are Crohn’s disease (CD), ulcerative colitis (UC) and inflammatory bowel disease undetermined (IBDU). The inflammation caused by Crohn's disease often spreads deep into the layers of affected bowel tissue.

Scientists at the University of Groningen (Groningen, The Netherlands) and their colleagues collected fecal samples, peripheral blood and extensive phenotype data from 291 patients with inflammatory bowel disease comprising 171 patients with CD, 104 patients with UC and 16 patients with IBDU and 476 healthy controls. For each participant, peripheral blood samples stored in EDTA tubes were available.

DNA extraction was performed using the Autopure LS with Puregene chemistry. Sample preparation was done by using Illumina Nextera prep kit and enrichment of the exonic sequences was performed by hybrid capture using Illumina rapid Capture Enrichment (37 mb target). The gut microbiome composition of stool samples was determined using tag-sequencing of the 16S rRNA gene. Fecal DNA was isolated by making aliquots and for the isolation of microbial DNA the Qiagen AllPrep DNA/RNA Mini Kit was used. Illumina MiSeq paired-end sequencing of the V4 region of the 16S rRNA gene was performed. The association between the SLC39A8 [Thr]391 risk allele and gut microbiome composition in patients with inflammatory bowel disease and healthy controls was inferred.

The team reported that Crohn’s disease patients were more often carriers of the missense variant (21/171, 12.3%) than controls (30/476, 6.3%) (OR = 2.1). They could not identify associations between carrier status and overall gut microbiome composition and microbial richness in all tested groups after correcting for potential confounding factors. They did identify 37 different operational taxonomical units to be associated with carrier status among the tested groups. Two of these 37 were identified before in the discovery study.

The authors concluded that that in future gene-microbiome studies much larger sample sizes, more stringent statistical analyses, especially with regard to mean counts of operational taxonomic units (OTUs) and correcting for confounding factors, replication in independent cohorts and elaborate descriptions of the methods used are needed to pinpoint genome-microbiome associations in both IBD and HC. They could identify the genetic variant to be associated with Crohn's disease, though the impact on the microbiome composition was limited to a few OTUs. The study was published on January 31, 2019, in the journal PLOS ONE.

Related Links:
University of Groningen


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PlGF Test
Quidel Triage PlGF Test
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.